Dr. Helen K. Li, MD

Dr. Li practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Li's NPI, 1598824740, was assigned on December 6, 2006. Dr. Li graduated from McGovern Medical School in 1986. Dr. Li's Texas license number on file is H1981.

Dr. Li's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Li's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Li is also affiliated with Houston Methodist Hospital. Dmand AI also links Dr. Li to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Li is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Li's licenses on file in 4 states: Texas, California, Tennessee and Pennsylvania.

Dmand AI lists age-related macular degeneration, conjunctivitis, dry eye, eyelid inflammation, glaucoma, inflammation of iris, retinal occlusion and surgical retina and vitreous procedures among the conditions Dr. Li treats.

CMS data shows 6,742 Medicare services from Dr. Li across 12 procedure codes in 2024, for 151 Medicare patients. Medicare paid $285,689 for them. Every service was in an office.

CMS counts 151 Medicare patients who saw Dr. Li in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 62, with 55% women.

In 2024, Dr. Li wrote 70 Medicare Part D claims for 24 patients. 46% of them were for generic drugs. CMS names the drug for 28 of them, across 1 drug with 11 or more claims each, at $58,643 in total drug cost. In 2023, CMS named 31 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Li for performance year 2024, reported individually. Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 43 papers to Dr. Li, published from 2008 to 2021. 2011 was the busiest year, with 4. The most frequent topics are Diabetic Retinopathy, Visual Acuity and Photography. Dr. Li has published most often in Ophthalmology. Dr. Li's most frequent co-authors are Andrew G. Lee, MD, Ronald P. Danis, MD and Amina I. Malik, MD.

Dmand AI links Dr. Li to 1 clinical trial. Conditions studied include Cytomegalovirus Retinitis and Retinitis.

CMS Open Payments shows 60 general payments to Dr. Li from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,161.

Dmand AI lists 1 award for Dr. Li.

Dr. Li graduated from McGovern Medical School in 1986. Dr. Li is a member of AAO.

Dr. Li is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.